Vir Biotechnology
-
Vir Biotechnology begins patient dosing in phase 2 MARCH study of combination of VIR-2218 & VIR-3434 as functional cure regimen for chronic HBV infection
89 0Vir Biotechnology announced that the first patient has been dosed…
Read more